Niagen Bioscience, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2020
Total Assets: $38.4M
Liabilities Breakdown FY2020
Total Liabilities: $21.9M
Asset Breakdown
Total Assets: $38.4M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $16.7M | 43.5% |
| Accounts Receivable | $2.7M | 7.0% |
| Inventory | $11.7M | 30.5% |
| Property, Plant & Equipment | $3.2M | 8.4% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $1.1M | 2.8% |
| Other Assets | $3.0M | 7.8% |
Liabilities Breakdown
Total Liabilities: $21.9M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $9.4M | 43.1% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $12.5M | 56.9% |